Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1186 of 6351
-
Immunotherapy before surgery shows promise for aggressive uterine cancer
Disease control OngoingThe goal of this clinical trial is to establish the fraction of patients that achieve a major pathological response (MPR) after 9 cycles of pembrolizumab, with the ultimate aim of informing a follow-up randomized trial. Participants will receive 9 cycles of pembrolizumab before …
Phase 2 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug shows promise for rare heart condition in chinese patients
Disease control OngoingThe purpose of this study is to investigate the effect of eplontersen compared to placebo on the reduction of serum TTR concentration and long-term safety in Chinese participants with hereditary or wild-type transthyretin amyloid cardiomyopathy.
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Which drug better prevents transplant complications in older leukemia patients?
Disease control Recruiting nowAllogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only curative therapy in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Most of the patients requiring an allo-HSCT are above 50 years of age and are transplanted with a reduced intensity…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
One pill to stop malaria? new combo shows promise
Disease control CompletedThis study evaluates the efficacy and safety of a single dose of M5717 plus pyronaridine tetraphosphate in clearing current Plasmodium falciparum infection and protecting against recurrent infections in asymptomatic adults and adolescents. The study will also assess the duration …
Phase 2 • Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Smartwatch and app could keep liver patients out of hospital
Disease control Recruiting nowThe CirrhoCare trial is a multi-centre, open label randomised controlled trial in patients with decompensated cirrhosis. The trial aims to investigate the clinical and cost-effectiveness of CirrhoCare digital home monitoring and management with current standard of care in these p…
Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could a 12-Week pill cocktail replace 6 months of TB treatment?
Disease control OngoingThe PRESCIENT trial is a Phase IIc, open-label, randomized trial that compared a 12-week regimen of bedaquiline (BDQ), clofazimine (CFZ), pyrazinamide (PZA), and delamanid (DLM) with standard treatment for drug-susceptible pulmonary tuberculosis (TB). Eligible participants were r…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a single pill cure scabies? new study tests three doses
Disease control CompletedMoxidectin is not approved to treat scabies in humans. The effective dose of moxidectin to treat scabies is not known. This study aims to assess the efficacy of a single administration of 8 mg, 16 mg, or 32 mg moxidectin per oral in achieving Scabies Complete Cure at Day 28. This…
Phase 2 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail aims to tackle obesity epidemic
Disease control Recruiting nowThe purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight management with intervention-specific appendices (ISAs). The CWMM establishes entr…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New pill aims to cut Parkinson's 'OFF' episodes
Symptom relief CompletedThe primary purpose of this study is to demonstrate the superiority of UCB0022 as an adjunctive treatment to stable dose of standard-of-care (SoC) (including at least levodopa therapy) over placebo with regard to motor fluctuations time spent in the OFF state (OFF time) in study …
Phase 2 • Sponsor: UCB Biopharma SRL • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New drug aims to tame rare inflammatory disease EGPA
Disease control Recruiting nowThis study is a phase 2/3 clinical trial to evaluate the efficacy and safety of SHR-1703 in patients with EGPA.
Phase 2/3 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New combo therapy aims to shrink rectal tumors before surgery
Disease control Recruiting nowIn this phase 2 study, the efficacy of total neoadjuvant therapy in Taiwanese patients with rectal cancer will be investigated. Patients with stage II or III middle/low rectal cancer will be prospective enrolled. The total neoadjuvant therapy with the short-course radiotherapy (5…
Phase 2 • Sponsor: National Cheng-Kung University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New trial aims to cut opioid use in pancreatic cancer with early nerve block
Symptom relief Recruiting nowPatients with unresectable pancreatic cancer are often demoralized by intractable, persistent and incapacitating pain. It must be managed aggressively and strong opioids are recommended as the mainstay of treatment. However, patients develop opioid-related adverse effects. EUS-gu…
Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
AI takes the wheel: smart insulin pump tested in toddlers
Disease control CompletedThe goal of this clinical trial is to obtain safety data and exploratory glycemic control data from use of an at-home closed loop control (CLC) system (t:slim X2 with Control-IQ Technology) with periodic parameter adjustments driven by an AI-based Advisor system in young children…
Sponsor: Marc Breton • Aim: Disease control
Last updated Jun 26, 2026 17:19 UTC
-
New eye drop shows promise for glaucoma patients
Disease control CompletedThe goal of this clinical trial is to test in patients with glaucoma and elevated pressure in the eye. The main questions it aims to answer are: • ability to lower pressure in the eye • safety in the eye and the body of patients with elevated pressure in the eye. Patients will be…
Phase 2 • Sponsor: Skye Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Pepper patch could ease tailbone pain without pills
Symptom relief Recruiting nowThe primary objective is to demonstrate the analgesic effect at day 60 of 8% capsaicin patch (Qutenza) for the treatment of patients with coccygodyinia.
Phase 3 • Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Could a cancer pill shrink kaposi tumors?
Disease control Recruiting nowThis phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Phase 2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a simple implant replace the morning-after pill?
Prevention Recruiting nowIntrauterine devices (IUDs) are highly effective to prevent pregnancy when used for emergency contraception (following unprotected intercourse in the last 3 days), but data are lacking for people who desire an etonogestrel (ENG) contraceptive implant in this situation. This propo…
Phase 4 • Sponsor: Lori Gawron • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Could a gentle brain ZAP boost speech recovery after stroke?
Disease control Recruiting nowThis study will assess the effects of transcranial alternating current stimulation (tACS) on language recovery after stroke.
Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New pill could help millions with uncontrolled diabetes
Disease control CompletedThe goal of this clinical study is to evaluate the efficacy and safety of Berberine Ursodeoxycholate (HTD1801) compared to placebo in patients with type 2 diabetes, inadequately controlled with diet and exercise alone.
Phase 3 • Sponsor: Shenzhen HighTide Biopharmaceutical Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New electric probe aims to catch hidden cancer cells during prostate removal
Diagnosis Recruiting nowThis research will study a custom device developed to detect if any prostate cancer tissue is left behind when the prostate is removed. This device is called an Electrical Impedance Imaging (EII) probe.
Sponsor: Ryan J. Halter • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC